Stocks and Investing
Stocks and Investing
Mon, July 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Oren Livnat Reiterated (VRCA) at Strong Buy and Held Target at $11 on, Jul 17th, 2023
Oren Livnat of HC Wainwright & Co., Reiterated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $11 on, Jul 17th, 2023.
Oren has made no other calls on VRCA in the last 4 months.
There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Glen Santangelo of "Jefferies" Initiated at Strong Buy and Held Target at $10 on, Wednesday, March 22nd, 2023
Contributing Sources